-
Something wrong with this record ?
Review: Genes Involved in Mitochondrial Physiology Within 22q11.2 Deleted Region and Their Relevance to Schizophrenia
D. Kolar, B. Krajcovic, L. Kleteckova, D. Kuncicka, K. Vales, H. Brozka
Language English Country United States
Document type Journal Article
Grant support
22-15096S
Czech Grant Agency
NU22J-04-00061
Agency for Health Research, Czech Republic
CZ.02.1.01/0.0/0.0/16_025/0007444
NIMH-CZ
NLK
Free Medical Journals
from 2006 to 1 year ago
PubMed Central
from 2006 to 1 year ago
Europe PubMed Central
from 2006 to 1 year ago
Medline Complete (EBSCOhost)
from 1996-01-01 to 1 year ago
- MeSH
- DiGeorge Syndrome * genetics MeSH
- Humans MeSH
- MicroRNAs * metabolism MeSH
- Mitochondria genetics metabolism MeSH
- RNA-Binding Proteins metabolism MeSH
- Ribonucleoproteins metabolism MeSH
- Ribosomal Proteins metabolism MeSH
- Schizophrenia * MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
BACKGROUND AND HYPOTHESIS: Schizophrenia is associated with altered energy metabolism, but the cause and potential impact of these metabolic changes remain unknown. 22q11.2 deletion syndrome (22q11.2DS) represents a genetic risk factor for schizophrenia, which is associated with the loss of several genes involved in mitochondrial physiology. Here we examine how the haploinsufficiency of these genes could contribute to the emergence of schizophrenia in 22q11.2DS. STUDY DESIGN: We characterize changes in neuronal mitochondrial function caused by haploinsufficiency of mitochondria-associated genes within the 22q11.2 region (PRODH, MRPL40, TANGO2, ZDHHC8, SLC25A1, TXNRD2, UFD1, and DGCR8). For that purpose, we combine data from 22q11.2DS carriers and schizophrenia patients, in vivo (animal models) and in vitro (induced pluripotent stem cells, IPSCs) studies. We also review the current knowledge about seven non-coding microRNA molecules located in the 22q11.2 region that may be indirectly involved in energy metabolism by acting as regulatory factors. STUDY RESULTS: We found that the haploinsufficiency of genes of interest is mainly associated with increased oxidative stress, altered energy metabolism, and calcium homeostasis in animal models. Studies on IPSCs from 22q11.2DS carriers corroborate findings of deficits in the brain energy metabolism, implying a causal role between impaired mitochondrial function and the development of schizophrenia in 22q11.2DS. CONCLUSIONS: The haploinsufficiency of genes within the 22q11.2 region leads to multifaceted mitochondrial dysfunction with consequences to neuronal function, viability, and wiring. Overlap between in vitro and in vivo studies implies a causal role between impaired mitochondrial function and the development of schizophrenia in 22q11.2DS.
3rd Faculty of Medicine Charles University Prague Czech Republic
Institute of Physiology Czech Academy of Sciences Prague Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24000590
- 003
- CZ-PrNML
- 005
- 20240213093257.0
- 007
- ta
- 008
- 240109s2023 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/schbul/sbad066 $2 doi
- 035 __
- $a (PubMed)37379469
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Kolar, David $u National Institute of Mental Health, Klecany, Czech Republic $1 https://orcid.org/000000024106871X
- 245 10
- $a Review: Genes Involved in Mitochondrial Physiology Within 22q11.2 Deleted Region and Their Relevance to Schizophrenia / $c D. Kolar, B. Krajcovic, L. Kleteckova, D. Kuncicka, K. Vales, H. Brozka
- 520 9_
- $a BACKGROUND AND HYPOTHESIS: Schizophrenia is associated with altered energy metabolism, but the cause and potential impact of these metabolic changes remain unknown. 22q11.2 deletion syndrome (22q11.2DS) represents a genetic risk factor for schizophrenia, which is associated with the loss of several genes involved in mitochondrial physiology. Here we examine how the haploinsufficiency of these genes could contribute to the emergence of schizophrenia in 22q11.2DS. STUDY DESIGN: We characterize changes in neuronal mitochondrial function caused by haploinsufficiency of mitochondria-associated genes within the 22q11.2 region (PRODH, MRPL40, TANGO2, ZDHHC8, SLC25A1, TXNRD2, UFD1, and DGCR8). For that purpose, we combine data from 22q11.2DS carriers and schizophrenia patients, in vivo (animal models) and in vitro (induced pluripotent stem cells, IPSCs) studies. We also review the current knowledge about seven non-coding microRNA molecules located in the 22q11.2 region that may be indirectly involved in energy metabolism by acting as regulatory factors. STUDY RESULTS: We found that the haploinsufficiency of genes of interest is mainly associated with increased oxidative stress, altered energy metabolism, and calcium homeostasis in animal models. Studies on IPSCs from 22q11.2DS carriers corroborate findings of deficits in the brain energy metabolism, implying a causal role between impaired mitochondrial function and the development of schizophrenia in 22q11.2DS. CONCLUSIONS: The haploinsufficiency of genes within the 22q11.2 region leads to multifaceted mitochondrial dysfunction with consequences to neuronal function, viability, and wiring. Overlap between in vitro and in vivo studies implies a causal role between impaired mitochondrial function and the development of schizophrenia in 22q11.2DS.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a schizofrenie $7 D012559
- 650 12
- $a DiGeorgeův syndrom $x genetika $7 D004062
- 650 12
- $a mikro RNA $x metabolismus $7 D035683
- 650 _2
- $a proteiny vázající RNA $x metabolismus $7 D016601
- 650 _2
- $a mitochondrie $x genetika $x metabolismus $7 D008928
- 650 _2
- $a ribonukleoproteiny $x metabolismus $7 D012261
- 650 _2
- $a ribozomální proteiny $x metabolismus $7 D012269
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Krajcovic, Branislav $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic $u Third Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Kleteckova, Lenka $u National Institute of Mental Health, Klecany, Czech Republic
- 700 1_
- $a Kuncicka, Daniela $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic $1 https://orcid.org/0000000286073408
- 700 1_
- $a Vales, Karel $u National Institute of Mental Health, Klecany, Czech Republic
- 700 1_
- $a Brozka, Hana $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
- 773 0_
- $w MED00004355 $t Schizophrenia bulletin $x 1745-1701 $g Roč. 49, č. 6 (2023), s. 1637-1653
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37379469 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240109 $b ABA008
- 991 __
- $a 20240213093254 $b ABA008
- 999 __
- $a ok $b bmc $g 2049322 $s 1210284
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 49 $c 6 $d 1637-1653 $e 2023Nov29 $i 1745-1701 $m Schizophrenia bulletin $n Schizophr Bull $x MED00004355
- GRA __
- $a 22-15096S $p Czech Grant Agency
- GRA __
- $a NU22J-04-00061 $p Agency for Health Research, Czech Republic
- GRA __
- $a CZ.02.1.01/0.0/0.0/16_025/0007444 $p NIMH-CZ
- LZP __
- $a Pubmed-20240109